Hydronephrosis Is an Independent Predictor of Poor Clinical Outcome in Patients Treated for Muscle-Invasive Transitional Cell Carcinoma With Radical Cystectomy
Daniel Canter(Ochsner Medical Center), S. Bruce Malkowicz(University of Pennsylvania), Alan J. Wein(University of Miami), Manish Vira(Hospital of the University of Pennsylvania), Benjamin M. Brucker(University of Pennsylvania), John Tomaszewski(Hospital of the University of Pennsylvania), Keith VanArsdalen(University of Pennsylvania), Zhen Chen(Eunice Kennedy Shriver National Institute of Child Health and Human Development), Matthew J. Resnick(Vanderbilt University Medical Center), Thomas J. Guzzo(Hospital of the University of Pennsylvania)
Cited by 33
Related Papers
Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Hypertension Awareness, Treatment, and Control in Adults With CKD: Results From the Chronic Renal Insufficiency Cohort (CRIC) Study
|American Journal of Kidney Diseases|2009|420